Prostate lesions with cribriform/pseudocribriform pattern

Romanian Journal of Morphology and Embryology

Volumn 51, Issue 3, 2010, Pages 413-425

  Dema, Alis ^a   Borda, Angela ^b   Lazǎr, Elena ^a   Lǎzureanu, Codruţa ^a   Tǎban, Sorina ^c   Anderco, Denisa ^c   Cornianu, Mǎrioara ^a   Mureşan, Anca ^a   Herman, Diana ^c   Loghin, Andrada ^b   Cornea, R ^a   Alexandra, Faur ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c Clinical Emergency County Hospital Pius Brinzeu Timisoara   (Romania)

Author keywords

Cribriform pseudocribriform pattern; Immunohistochemistry; Prostate

Indexed keywords

ADENOCARCINOMA; HUMAN; HYPERPLASIA; MALE; PATHOLOGY; PROSTATE; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REVIEW;

ADENOCARCINOMA; HUMANS; HYPERPLASIA; MALE; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 77957012945     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. LATOUR M, AMIN MB, BILLIS A, EGEVAD L, GRIGNON DJ, HUMPHREY PA, REUTER VE, SAKR WA, SRIGLEY JR, WHEELER TM, YANG XJ, EPSTEIN JI, Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology, Am J Surg Pathol, 2008, 32(10):1532-1539.
2. MCNEAL JE, Normal and pathologic anatomy of prostate, Urology, 1981, 17(Suppl 3):11-16.
3. EPSTEIN JI, Precursor lesions to prostatic adenocarcinoma, Virchows Arch, 2009, 454(1):1-16.
4. rd series, fascicle 28, Armed Forces Institute of Pathology, Washington, DC, 2000, 9-14.
5. AYALA AG, High-Grade Prostatic Intraepithelial Neoplasia. Specialty Conference, Genitourinary Pathology, USCAP Annual Meeting, 2004, www.uscap.org/.
6. ZHOU M, MAGI-GALLUZZI C, Prostatic adenocarcinoma, prostatic intraepithelial neoplasia, and intraductal carcinoma. In: PARWANI AV, GOLDBLUM JR (eds), Current concepts in genitourinary pathology: prostate and bladder, Surgical Pathology Clinics, 2008, 1(1):43-76.
7. KRONZ JD, SHAIKH AA, EPSTEIN JI, Atypical cribriform lesions on prostate biopsy, Am J Surg Pathol, 2001, 25(2):147-155.
8. th edition, Lippincott Williams & Wilkins, Philadelphia, 2008, 35-71.
9. TRONCOSO P, BABAIAN RJ, RO JY, GRIGNON DJ, VON ESCHENBACH AC, AYALA AG, Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens, Urology, 1989, 34(6 Suppl):52-56.
10. AYALA AG, SRIGLEY JR, RO JY, ABDUL-KARIM FW, JOHNSON DE, Clear cell cribriform hyperplasia of prostate. Report of 10 cases, Am J Surg Pathol, 1986, 10(10):665-671.
11. FRAUENHOFFER EE, RO JY, EL-NAGGAR AK, ORDÓÑEZ NG, AYALA AG, Clear cell cribriform hyperplasia of the prostate. Immunohistochemical and DNA flow cytometric study, Am J Clin Pathol, 1991, 95(4):446-453.
12. NETTO GJ, EPSTEIN JI, Benign mimickers of prostate adenocarcinoma on needle biopsy and transurethral resection. In: PARWANI AV, GOLDBLUM JR (eds), Current concepts in genitourinary pathology: prostate and bladder, Surgical Pathology Clinics, 2008, 1(1):1-42.
13. rd series, fascicle 28, Armed Forces Institute of Pathology, Washington, DC, 2000, 297-298.
14. SRIGLEY JR, Benign mimickers of prostatic adenocarcinoma, Symposium 01. Benign mimics and tumor-like lesions in urologic pathology, IAP 2006 Annual Congress, 2006. http://www.uscap.org/.
15. th edition, Lippincott Williams & Wilkins, Philadelphia, 2008, 105-156 b.
16. MONTIRONI R, Ordinary and florid BCH (patterns 1 and 2) and basal cell carcinoma (pattern 3) with focal areas resembling BCH, Specialty Conference, Genitourinary Pathology, USCAP Annual Meeting, 2006, http://www.uscap.org/.
17. MONTIRONI R, MAZZUCCHELLI R, STRAMAZZOTTI D, SCARPELLI M, LÓPEZ-BELTRAN A, BOSTWICK DG, Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression, J Clin Pathol, 2005, 58(3):290-296.
18. BOSTWICK DG, Mimics of prostate cancer, ISUP 2004 Annual Meeting, http://www.uscap.org/.
19. GRIGNON DJ, RO JY, ORDOÑEZ NG, AYALA AG, CLEARY KR, Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study, Hum Pathol, 1988, 19(12):1425-1433.
20. EPSTEIN JI, ARMAS OA, Atypical basal cell hyperplasia of the prostate, Am J Surg Pathol, 1992, 16(12):1205-1214.
21. DEVARAJ LT, BOSTWICK DG, Atypical basal cell hyperplasia of the prostate. Immunophenotypic profile and proposed classification of basal cell proliferations, Am J Surg Pathol, 1993, 17(7):645-659.
22. THORSON P, SWANSON PE, VOLLMER RT, HUMPHREY PA, Basal cell hyperplasia in the peripheral zone of the prostate, Mod Pathol, 2003, 16(6):598-606.
23. RIOUX-LECLERCQ NC, EPSTEIN JI, Unusual morphologic patterns of basal cell hyperplasia of the prostate, Am J Surg Pathol, 2002, 26(2):237-243.
24. ICZKOWSKI KA, FERGUSON KL, GRIER DD, HOSSAIN D, BANERJEE SS, MCNEAL JE, BOSTWICK DG, Adenoid cystic/basal cell carcinoma of the prostate: clinicopathologic findings in 19 cases, Am J Surg Pathol, 2003, 27(12):1523-1529.
25. GRIGNON DJ, Unusual subtypes of prostate cancer, Mod Pathol, 2004, 17(3):316-327.
26. YANG XJ, MCENTEE M, EPSTEIN JI, Distinction of basaloid carcinoma of the prostate from benign basal cell lesions by using immunohistochemistry for bcl-2 and Ki-67, Hum Pathol, 1998, 29(12):1447-1450.
27. ALI TZ, EPSTEIN JI, Basal cell carcinoma of the prostate: a clinicopathologic study of 29 cases, Am J Surg Pathol, 2007, 31(5):697-705.
28. SHAH IA, SCHLAGETER MO, STINNETT P, LECHAGO J, Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate, Mod Pathol, 1991, 4(2):220-224.
29. ICZKOWSKI KA, Current prostate biopsy interpretation: criteria for cancer, atypical small acinar proliferation, highgrade prostatic intraepithelial neoplasia, and use of immunostain, Arch Pathol Lab Med, 2006, 130(6):835-843.
30. YANG XJ, TRETIAKOVA MS, SENGUPTA E, GONG C, JIANG Z, Florid basal cell hyperplasia of the prostate: a histological, ultrastructural, and immunohistochemical analysis, Hum Pathol, 2003, 34(5):462-470.
31. BOSTWICK DG, BRAWER MK, Prostatic intra-epithelial neoplasia and early invasion in prostate cancer, Cancer, 1987, 59(4):788-794.
32. BOSTWICK DG, AMIN MB, DUNDORE P, MARSH W, SCHULTZ DS, Architectural patterns of high-grade prostatic intraepithelial neoplasia, Hum Pathol, 1993, 24(3):298-310.
33. BOSTWICK DG, QIAN J, High-grade prostatic intraepithelial neoplasia, Mod Pathol, 2004, 17(3):360-379.
34. WU CL, YANG XJ, TRETIAKOVA M, PATTON KT, HALPERN EF, WODA BA, YOUNG RH, JIANG Z, Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia, Hum Pathol, 2004, 35(8):1008-1013.
35. VARMA M, JASANI B, Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature, Histopathology, 2005, 47(1):1-16.
36. PICKUP M, VAN DER KWAST TH, My approach to intraductal lesions of the prostate gland, J Clin Pathol, 2007, 60(8):856-865.
37. rd series, fascicle 28, Armed Forces Institute of Pathology, Washington, DC, 2000, 69-94(c).
38. JIANG Z, WODA BA, ROCK KL, XU Y, SAVAS L, KHAN A, PIHAN G, CAI F, BABCOOK JS, RATHANASWAMI P, REED SG, XU J, FANGER GR, P504S: a new molecular marker for the detection of prostate carcinoma, Am J Surg Pathol, 2001, 25(11):1397-1404.
39. JIANG Z, WU CL, WODA BA, ICZKOWSKI KA, CHU PG, TRETIAKOVA MS, YOUNG RH, WEISS LM, BLUTE RD JR, BRENDLER CB, KRAUSZ T, XU JC, ROCK KL, AMIN MB, YANG XJ, Alpha-methylacyl-CoA racemase: a multiinstitutional study of a new prostate cancer marker, Histopathology, 2004, 45(3):218-225.
40. ZHOU M, AYDIN H, KANANE H, EPSTEIN JI, How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?, Am J Surg Pathol, 2004, 28(2):239-243.
41. HERAWI M, EPSTEIN JI, Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate, Am J Surg Pathol, 2007, 31(6):889-894.
42. EPSTEIN JI, HERAWI M, Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care, J Urol, 2006, 175(3 Pt 1):820-834.
43. MONTIRONI R, MAZZUCCHELLI R, LOPEZ-BELTRAN A, CHENG L, SCARPELLI M, Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate, Nat Clin Pract Urol, 2007, 4(6):322-332.
44. VAN DER KWAST TH, LOPES C, SANTONJA C, PIHL CG, NEETENS I, MARTIKAINEN P, DI LOLLO S, BUBENDORF L, HOEDEMAEKER RF; MEMBERS OF THE PATHOLOGY COMMITTEE OF THE EUROPEAN RANDOMISED STUDY OF SCREENING FOR PROSTATE CANCER, Guidelines for processing and reporting of prostatic needle biopsies, J Clin Pathol, 2003, 56(5):336-340.
45. EGEVAD L, ALLSBROOK WC JR, EPSTEIN JI, Current practice of diagnosis and reporting of prostatic intraepithelial neoplasia and glandular atypia among genitourinary pathologists, Mod Pathol, 2006, 19(2):180-185.
46. CHRISTENSEN WN, STEINBERG G, WALSH PC, EPSTEIN JI, Prostatic duct adenocarcinoma. Findings at radical prostatectomy, Cancer, 1991, 67(8):2118-2124.
47. EPSTEIN JI, GRIGNON DJ, HUMPHREY PA, MCNEAL JE, SESTERHENN IA, TRONCOSO P, WHEELER TM, Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia, Am J Surg Pathol, 1995, 19(8):873-886.
48. ABRAHAMS NA, ORMSBY AH, BRAINARD J, Validation of cytokeratin 5/6 as an effective substitute for keratin 903 in the differentiation of benign from malignant glands in prostate needle biopsies, Histopathology, 2002, 41(1):35-41.
49. ZHOU M, SHAH R, SHEN R, RUBIN MA, Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells, Am J Surg Pathol, 2003, 27(3):365-371.
50. TAVORA F, EPSTEIN JI, High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases, Am J Surg Pathol, 2008, 32(7):1060-1067.
51. MCNEAL JE, ALROY J, LEAV I, REDWINE EA, FREIHA FS, STAMEY TA, Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis, Am J Clin Pathol, 1988, 90(1):23-32.
52. HELPAP B, EGEVAD L, The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens, Virchows Arch, 2006, 449(6):622-627.
53. EPSTEIN JI, ALSBROOK WC JR, AMIN MB, EGEVAD LL; ISUP GRADING COMMITTEE, The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma, Am J Surg Pathol, 2005, 29(9):1228-1242.
54. QIAN J, JENKINS RB, BOSTWICK DG, Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization, Mod Pathol, 1996, 10(11):1113-1119.
55. GOLDSTEIN NS, UNDERHILL J, ROSZKA J, NEILL JS, Cytokeratin 34beta E-12 immunoreactivity in benign prostatic acini. Quantitation, pattern assessment, and electron microscopic study, Am J Clin Pathol, 1999, 112(1):69-74.
56. COHEN RJ, WHEELER TM, BONKHOFF H, RUBIN MA, A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma, Arch Pathol Lab Med, 2007, 131(7): 1103-1109.
57. rd series, fascicle 28, Armed Forces Institute of Pathology, Washington, DC, 2000, 289-334.
58. FINE SW, Variants and unusual pattern of prostate cancer. In: PARWANI AV, GOLDBLUM JR (eds), Current concepts in genitourinary pathology: prostate and bladder, Surgical Pathology Clinics, 2008, 1(1):77-104.
59. th edition, Lippincott Williams & Wilkins, Philadelphia, 2008, 218-227.
60. BRINKER DA, POTTER SR, EPSTEIN JI, Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy finding and progression, Am J Surg Pathol, 1999, 23(12):1471-1479.
61. AMIN M, BOCCON-GIBOD L, EGEVAD L, EPSTEIN JI, HUMPHREY PA, MIKUZ G, NEWLING D, NILSSON S, SAKR W, SRIGLEY JR, WHEELER TM, MONTIRONI R, Prognostic and predictive factors and reporting of prostate carcinoma in needle biopsy specimens, Scand J Urol Nephrol Suppl, 2005, (216):20-33.
62. SATO K, TACHIBANA H, TSUZUKI T, UEDA Y, KATSUDA S, Prostatic ductal adenocarcinoma mimicking villous adenoma of the urethra, Virchows Arch, 2006, 449(5):597-599.
63. HELPAP B, The significance of the P504S expression pattern of high-grade prostatic intraepithelial neoplasia (HGPIN) with and without adenocarcinoma of the prostate in biopsy and radical prostatectomy specimens, Virchows Arch, 2006, 448(4):480-484.
64. GUO CC, EPSTEIN JI, Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance, Mod Pathol, 2006, 19(12):1528-1535.
65. MCNEAL JE, YEMOTO CE, Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlation, Am J Surg Pathol, 1996, 20(7):802-814.
66. COHEN RJ, MCNEAL JE, BAILLIE T, Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: significance for cancer progression, Prostate, 2000, 43(1):11-19.
67. SHAH RB, MAGI-GALLUZZI C, HAN B, ZHOU M, Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies, Am J Surg Pathol, 2010, 34(4):470-477.
68. MONTIRONI E, MAZZUCCHELLI R, ALGABA F, LOPEZ-BELTRAN A, Morphological identification of the patterns of prostatic intraepithelial neoplasia and their significance, J Clin Pathol, 2000, 53(9):655-665.
69. OWENS CL, EPSTEIN JI, NETTO GJ, Distinguishing prostatic from colorectal adenocarcinoma on biopsy samples: the role of morphology and immunohistochemistry, Arch Pathol Lab Med, 2007, 131(4):599-603.
70. HAMEED O, HUMPHREY PA, Immunohistochemistry in diagnostic surgical pathology of the prostate, Semin Diagn Pathol, 2005, 22(1):88-104.
71. LANE Z, HANSEL DE, EPSTEIN JI, Immunohistochemical expression of prostatic antigens in adenocarcinoma and vilous adenoma of the urinary bladder, Am J Surg Pathol, 2008, 32(9):1322-1326.